- Home
- AMST vs ALLR Comparison
AMST vs ALLR Comparison
Compare AMST & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMST
- ALLR
- Stock Information
- Founded
- AMST 2017
- ALLR 2004
- Country
- AMST United States
- ALLR United States
- Employees
- AMST N/A
- ALLR N/A
- Industry
- AMST Computer Software: Prepackaged Software
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- AMST Technology
- ALLR Health Care
- Exchange
- AMST Nasdaq
- ALLR Nasdaq
- Market Cap
- AMST 13.3M
- ALLR 15.8M
- IPO Year
- AMST 2020
- ALLR N/A
- Fundamental
- Price
- AMST $2.74
- ALLR $1.97
- Analyst Decision
- AMST
- ALLR Strong Buy
- Analyst Count
- AMST 0
- ALLR 1
- Target Price
- AMST N/A
- ALLR $9.00
- AVG Volume (30 Days)
- AMST 14.0K
- ALLR 21.3M
- Earning Date
- AMST 09-29-2025
- ALLR 08-15-2025
- Dividend Yield
- AMST N/A
- ALLR N/A
- EPS Growth
- AMST N/A
- ALLR N/A
- EPS
- AMST N/A
- ALLR N/A
- Revenue
- AMST $82,544.00
- ALLR N/A
- Revenue This Year
- AMST N/A
- ALLR N/A
- Revenue Next Year
- AMST N/A
- ALLR N/A
- P/E Ratio
- AMST N/A
- ALLR N/A
- Revenue Growth
- AMST N/A
- ALLR N/A
- 52 Week Low
- AMST $2.00
- ALLR $0.61
- 52 Week High
- AMST $6.27
- ALLR $5.20
- Technical
- Relative Strength Index (RSI)
- AMST 47.08
- ALLR 78.81
- Support Level
- AMST $2.63
- ALLR $1.36
- Resistance Level
- AMST $2.83
- ALLR $1.77
- Average True Range (ATR)
- AMST 0.13
- ALLR 0.22
- MACD
- AMST 0.01
- ALLR 0.09
- Stochastic Oscillator
- AMST 53.85
- ALLR 74.83
About AMST Amesite Inc.
Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.